Why Should You Care About Gap Analysis?
Meaningful Use, the changeover to ICD-10, the 2013 HIPAA Final Omnibus Rule, among other drivers, makes it clear that integration is an essential, critical process.
Home » HL7 Interfacing » Page 4
Meaningful Use, the changeover to ICD-10, the 2013 HIPAA Final Omnibus Rule, among other drivers, makes it clear that integration is an essential, critical process.
What is Your Biggest Interfacing Challenge? To gain insight into the issues our users are facing, there is one key question we ask when a
How to Handle Break-Fix Issues During the validation phase of the interface lifecycle, you’re running tests. Here’s more on testing: test scenarios and test systems as
Message Player, our free HL7 listener/router utility designed for HIT software developers, interface developers, and interface analysts, is now out. You might have seen other
We’ve shipped our latest software to beta testers. And we’ve given the product a name: Caristix Reader. Like Adobe Reader, it’s free. Looking for more
Some organizations call them HL7 conformance profiles, others call them HL7 interface specifications. They’re all talking about a description of the data format used for
I recently had a discussion with some of our partners around conformance profiles and templates. Collectively, we haven’t come across an industry-standard template. Some organizations
Definition Let’s start with the formal definition, introduced by the HL7 organization in the v2.5 specification. Here is an excerpt from section 2.12: Definition: An
What can you do to improve the HL7 interface validation process on your next implementation project? I was on-site at a hospital where a vendor
In Part 1 of this series on HL7 gap analysis, I covered the need to identify gaps before starting to configure an interface, and explained
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.